Cochlear completes pivotal trial enrollment for its fully implantable hearing device. CTO shares insights on design, safety, ...

Guardant Health's Shield blood test wins the 2026 Prix Galien USA Award for Best Medical Technology, recognizing its impact ...

Boston Scientific's SIMPLAAFY data show aspirin alone or reduced-dose anticoagulation matches DAPT after Watchman Flx Pro ...

Explore questions and considerations that come into play when moving an additive application from design freeze toward ...

Few medtech firms use FDA's PCCP pathway because most lack the MLOps infrastructure needed to safely iterate AI models ...

Edwards' PROGRESS Trial found TAVR cut death or heart failure risk by a third versus surveillance in moderate aortic stenosis patients at TCT 2026.

Boston Scientific cuts Q4 guidance as cyberattack fallout and EP and Watchman market pressures weigh on growth heading into ...

Dexcom's landmark CONNECT trial, now published in the NEJM, could drive a pivotal CMS coverage decision for type 2 diabetes patients this year.

Dyconex created a biocompatible PCB platform that shrinks medical device interconnects while boosting functionality and ...

Stryker lowered its 2026 sales and EPS guidance after a Q3 miss, citing slowing joint replacement demand and ...

Rocco De Bernardis of J&J MedTech breaks down Ottava's design, FDA clearance, and vision for multi-specialty growth.

Make no mistake about it, history was made in Florida on Oct. 25, and the surgical team’s excitement is well earned. Next comes the hard part — getting regulatory, reimbursement, and hospital ...